Oral Communications & Posters
2022
AACR Annual Meeting
SMARCA4-mediated chromatin remodeling regulates osimertinib resistance in EGFR-mutant lung adenocarcinoma.
de Miguel FJ. et al
Scholar-In-Training Awardee 
AACR | New Orleans, LA 
2021
Patient Derived Models of Cancer Consortium 3rd Annual Meeting
Investigating epigenetic mechanisms of resistance to tyrosine kinase inhibitors using patient-derived models of lung cancer.
de Miguel FJ.
NIH/NCI | Online
ASIP 2021 Annual Meeting. SIPMeT Symposium: Epigenetic Regulation and Cancer
Epigenetic regulation and TKI resistance in EGFR-mutant lung cancer: A new role of SMARCA4.
de Miguel FJ.
ASIP | Online
2020
Annual EGFR Resisters Research Summit
The Chromatin Remodeling Factor SMARCA4 Regulates Proliferation and Oxidative Stress in Osimertinib Resistant EGFR-mutant Lung Adenocarcinoma.
de Miguel FJ.
Honorable Mention Research Award
EGFR Resisters | Online
Sixth AACR-IASLC International Joint Conference: Lung Cancer Translational Science from the Bench to the Clinic.
The role of SMARCA4 as an EGFR-independent mechanism of resistance to osimertinib.
de Miguel FJ. et al.
AACR | IASLC | San Diego, CA
2019
Lung Cancer SPORE Workshop
BRG1 as a Mediator of Resistance to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma.
de Miguel FJ. et al.
NIH/NCI | Rockville, MD
Yale Cancer Center Annual Retreat
BRG1 as a Mediator of Resistance to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma.
de Miguel FJ. et al.
Poster Award
Yale Cancer Center | New Haven, CT
NCI Symposium on Mechanisms of Cancer Drug Resistance and Sensitivity
Elucidating the Role of SMARCA4/BRG1 as Mediator of TKI Resistance in Lung Adenocarcinomas.
de Miguel FJ. et al.
NIH/NCI | Rockville, MD
2018
Lung Cancer SPORE Workshop
Chromatin Modifiers as Mediators of Drug Resistance in Lung Cancer.
de Miguel FJ. et al.
UT Southwestern | Dallas, TX
2015
V RTICC Young Researchers Meeting
Large scale analysis of alternative splicing enforces QKI as a key regulator in lung cancer.
de Miguel FJ. et al.
RTICC | Pamplona, Spain 
AACR Annual Meeting
Analysis of the functional relevance of novel alternative splicing events in non-small cell lung cancer.
de Miguel FJ. et al
RTICC Travel Awardee
AACR | Philadelphia, PA
2014
IV RTICC Young Researchers Meeting
Identification of New Alternative Splicing Events in Lung Cancer.
de Miguel FJ. et al.
RTICC | Salamanca, Spain
2012
III IMPPC Annual Conference: RNA Biology in Cancer and other Diseases
Identification of splice variants regulated by the oncogene ASF/SF2 in lung cancer.
de Miguel FJ. et al.
IMPPC | Barcelona, Spain
Fernando de Miguel, PhD. 